Abstract
Primary immunodeficiencies (PIDs) belong to a group of rare congenital diseases occurring all over the world that may be seen in both children and adults. In most cases, genetic predispositions are already known. As shown in this review, genetic abnormalities may be related to dysfunction of the immune system, which manifests itself as recurrent infections, increased risk of cancer, and autoimmune diseases. This article reviews the various forms of PIDs, including their characterization, management strategies, and complications. Novel aspects of the diagnostics and monitoring of PIDs are presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abraham RS, Aubert G (2016) Flow cytometry, a versatile tool for diagnosis and monitoring of primary immunodeficiencies. Clin Vaccine Immunol 23(4):254–271
Agarwal S, Mayer L (2013) Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol 11(9):1050–1063
Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, Scaramuzza S, Andolfi G, Mirolo M, Brigida I, Tabucchi A, Carlucci F, Eibl M, Aker M, Slavin S, Al-Mousa H, Al Ghonaium A, Ferster A, Duppenthaler A, Notarangelo L, Wintergerst U, Buckley RH, Bregni M, Marktel S, Valsecchi MG, Rossi P, Ciceri F, Miniero R, Bordignon C, Roncarolo MG (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360:447–458
Albin S, Cunningham-Rundles C (2014) An update on the use of immunoglobulin for the treatment of immunodeficiency disorders. Immunotherapy 6(10):1113–1126
Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, Etzioni A, Franco JL, Gaspar HB, Holland SM, Klein C, Nonoyama S, Ochs HD, Oksenhendler E, Picard C, Puck JM, Sullivan K, Tang ML (2014) Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 5:162
Alper CA, Marcus-Bagley D, Awdeh Z, Kruskall MS, Eisenbarth GS, Brink SJ, Katz A, Stein R, Bing DH, Yunis EJ, Schur PH (2000) Prospective analysis suggests susceptibility genes for deficiencies of IgA and several other immunoglobulins on the [HLA-B8, SC01, DR3] conserved extended haplotype. Tissue Antigens 56:207–216
Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, Fasth A, Heilmann C, Wulffraat N, Seger R, Blanche S, Friedrich W, Abinun M, Davies G, Bredius R, Schulz A, Landais P, Fischer A (2003) Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 361:553–560
Arkwright PD, Gennery AR (2011) Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century. Ann N Y Acad Sci 1238:7–14
Arkwright PD, Abinum M, Cant AJ (2002) Autoimmunity in human primary immunodeficiency diseases. Blood 99(8):2694–2702
Azizi G, Ahmadi M, Abolhassani H, Yazdani R, Mohammadi H, Mirshafiey A, Rezaei N, Aghamohammadi A (2016) Autoimmunity in primary antibody deficiencies. Int Arch Allergy Immunol 171(3–4):180–193
Bazregari S, Azizi G, Tavakol M, Asgardoon MH, Kiaee F, Tavakolinia N, Valizadeh A, Abolhassani H, Aghamohammadi A (2017) Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency. Cent Eur J Immunol 42(4):336–341
Bernatowska E, Zeman K, Lewandowicz-Uszyńska A, Kurenko-Deptuch M, Pac M, Wolska-Kuśnierz B, Mikoluc B (2007) The Polish working group for primary immunodeficiency. Cent Eur J Immunol 32(1):34–40
Bestas B, Moreno PM, Blomberg KE, Mohammad DK, Saleh AF, Sutlu T, Nordin JZ, Guterstam P, Gustafsson MO, Kharazi S, Piątosa B, Roberts TC, Behlke MA, Wood MJ, Gait MJ, Lundin KE, El Andaloussi S, Månsson R, Berglöf A, Wengel J, Smith CI (2014) Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model. J Clin Invest 124:4067–4081
Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF (1995) T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270:475–480
Bogunia-Kubik K, Sugisaka M (2002) From molecular biology to nanotechnology and nanomedicine. Biosystems 65:123–138
Boisson B, Quartier P, Casanova JL (2015) Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind. Curr Opin Immunol 32:90–105
Bolze A, Byun M, McDonald D, Morgan NV, Abhyankar A, Premkumar L, Puel A, Bacon CM, Rieux-Laucat F, Pang K, Britland A, Abel L, Cant A, Maher ER, Riedl SJ, Hambleton S, Casanova JL (2010) Whole-exome-sequencing-based discovery of human FADD deficiency. Am J Hum Genet 87:873–881
Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, Keller M, Kobrynski LJ, Komarow HD, Mazer B, Nelson RP Jr, Orange JS, Routes JM, Shearer WT, Sorensen RU, Verbsky JW, Bernstein DI, Blessing-Moore J, Lang D, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph CR, Schuller D, Spector SL, Tilles S, Wallace D (2015) Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol 136(5):1186–1205
Booth C, Gaspar HB (2009) Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID). Biologics 3:349–358
Borte S, Wang N, Oskarsdottir S, von Döbeln U, Hammarström L (2011a) Newborn screening for primary immunodeficiencies: beyond SCID and XLA. Ann N Y Acad Sci 1246:118–130
Borte M, Bernatowska E, Ochs HD, Roifman CM, Vivaglobin Study Group (2011b) Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies. Clin Exp Immunol 164(3):357–364
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, Etzioni A, Fischer A, Franco JL, Geha RS, Hammarström L, Nonoyama S, Ochs HD, Roifman CM, Seger R, Tang ML, Puck JM, Chapel H, Notarangelo LD, Casanova JL (2013) A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol 33(6):1078–1087
Boyarchuk O, Volyanska L, Dmytrash L (2017) Clinical variability of chromosome 22q11.2 deletion syndrome. Cent Eur J Immunol 42(4):412–417
Boyle JM, Buckley RH (2007) Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol 27:497–502
Boztug K, Schmidt M, Schwarzer A, Banerjee PP, Díez IA, Dewey RA, Böhm M, Nowrouzi A, Ball CR, Glimm H, Naundorf S, Kühlcke K, Blasczyk R, Kondratenko I, Maródi L, Orange JS, von Kalle C, Klein C (2010) Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med 363:1918–1927
Bruton OC (1952) Agammaglobulinemia. Pediatrics 9(6):722–728
Candotti F, Shaw KL, Muul L, Carbonaro D, Sokolic R, Choi C, Schurman SH, Garabedian E, Kesserwan C, Jagadeesh GJ, Fu PY, Gschweng E, Cooper A, Tisdale JF, Weinberg KI, Crooks GM, Kapoor N, Shah A, Abdel-Azim H, Yu XJ, Smogorzewska M, Wayne AS, Rosenblatt HM, Davis CM, Hanson C, Rishi RG, Wang X, Gjertson D, Yang OO, Balamurugan A, Bauer G, Ireland JA, Engel BC, Podsakoff GM, Hershfield MS, Blaese RM, Parkman R, Kohn DB (2012) Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood 120:3635–3646
Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, Vidaud M, Abel U, Dal-Cortivo L, Caccavelli L, Mahlaoui N, Kiermer V, Mittelstaedt D, Bellesme C, Lahlou N, Lefrère F, Blanche S, Audit M, Payen E, Leboulch P, l’Homme B, Bougnères P, Von Kalle C, Fischer A, Cavazzana-Calvo M, Aubourg P (2009) Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326:818–823
Castellano G, Moreno D, Galvao O, Ballestín C, Colina F, Mollejo M, Morillas JD, Solís Herruzo JA (1992) Malignant lymphoma of jejunum with common variable hypogammaglobulinemia and diffuse nodular hyperplasia of the small intestine. A case study and literature review. J Clin Gastroenterol 15:128–135
Castiello MC, Bosticardo M, Pala F, Catucci M, Chamberlain N, van Zelm MC, Driessen GJ, Pac M, Bernatowska E, Scaramuzza S, Aiuti A, Sauer AV, Traggiai E, Meffre E, Villa A, van der Burg M (2014) Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans. J Autoimmun 50:42–50
Chrzanowska KH, Digweed M, Sperling K, Seemanova E (2009) DNA-repair deficiency and cancer: lessons from lymphoma. In: Allgayer H, Rehder H, Fulda S (eds) Hereditary tumors: from genes to clinical consequences. Wiley, Hoboken, pp 377–391
Conley ME, Casanova JL (2014) Discovery of single-gene inborn errors of immunity by next generation sequencing. Curr Opin Immunol 30C:17–23
Cunningham-Rundles C (2011) Autoimmunity in primary immune deficiency: taking lessons from our patients. Clin Exp Immunol 164(Suppl 2):6–11
Dembowska-Baginska B, Perek D, Brozyna A, Wakulinska A, Olczak-Kowalczyk D, Gladkowska-Dura M, Grajkowska W, Chrzanowska KH (2009) Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS). Pediatr Blood Cancer 52(2):186–190
Dong J, Liang H, Wen D, Wang J (2016) Adult common variable immunodeficiency. Am J Med Sci 351(3):239–243
Durandy A, Kracker S, Fischer A (2013) Primary antibody deficiencies. Nat Rev Immunol 13(7):519–533
Eades-Perner AM, Gathmann B, Knerr V, Guzman D, Veit D, Kindle G, Grimbacher B (2007) The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol 147(2):306–312
Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M (2013) Gene therapy of primary T cell immunodeficiencies. Gene 525:170–173
Froňková E, Klocperk A, Svatoň M, Nováková M, Kotrová M, Kayserová J, Kalina T, Keslová P, Votava F, Vinohradská H, Freiberger T, Mejstříková E, Trka J, Sedivá A (2014) The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome. PLoS One 9(1–13):e114514
Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, Sinclair J, Brouns G, Schmidt M, Von Kalle C, Barington T, Jakobsen MA, Christensen HO, Al Ghonaium A, White HN, Smith JL, Levinsky RJ, Ali RR, Kinnon C, Thrasher AJ (2004) Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364(9452):2181–2187
Gaspar HB, Cooray S, Gilmour KC, Parsley KL, Zhang F, Adams S, Bjorkegren E, Bayford J, Brown L, Davies EG, Veys P, Fairbanks L, Bordon V, Petropoulou T, Kinnon C, Thrasher AJ (2011) Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction. Sci Transl Med 3(97):97ra80
Gennery AR (2016) The sting of WASP deficiency: autoimmunity exposed. Blood 127(2):173–175
Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P, Amrolia PJ, Gaspar HB, Davies EG, Friedrich W, Hoenig M, Notarangelo LD, Mazzolari E, Porta F, Bredius RG, Lankester AC, Wulffraat NM, Seger R, Güngör T, Fasth A, Sedlacek P, Neven B, Blanche S, Fischer A, Cavazzana-Calvo M, Landais P (2010) Transplantation of hematopoietic stem cells and long term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol 126:602–610
Gompels MM, Hodges E, Rj L, Angus B, White H, Larkin A, Chapel HM, Spickett GP, Misbah SA, JL S, Associated Study Group (2003) Lymphoproliferative disease in antibody deficiency: a multi-Centre study. Clin Exp Immunol 134(2):314–320
Griffith LM, Cowan MJ, Notarangelo LD, Puck JM, Buckley RH, Candotti F, Conley ME, Fleisher TA, Gaspar HB, Kohn DB, Ochs HD, O’Reilly RJ, Rizzo JD, Roifman CM, Small TN, Shearer WT (2009) Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. J Allergy Clin Immunol 124:1152–1160
Gulácsy V, Freiberger T, Shcherbina A, Pac M, Chernyshova L, Avcin T, Kondratenko I, Kostyuchenko L, Prokofjeva T, Pasic S, Bernatowska E, Kutukculer N, Rascon J, Iagaru N, Mazza C, Tóth B, Erdos M, van der Burg M, Maródi L, J Project Study Group (2011) Genetic characteristics of eighty-seven patients with the Wiskott-Aldrich syndrome. Mol Immunol 48:788–792
Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, Martinache C, Rieux-Laucat F, Latour S, Belohradsky BH, Leiva L, Sorensen R, Debré M, Casanova JL, Blanche S, Durandy A, Bushman FD, Fischer A, Cavazzana-Calvo M (2010) Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 363:355–364
Hassan A, Booth C, Brightwell A, Allwood Z, Veys P, Rao K, Hönig M, Friedrich W, Gennery A, Slatter M, Bredius R, Finocchi A, Cancrini C, Aiuti A, Porta F, Lanfranchi A, Ridella M, Steward C, Filipovich A, Marsh R, Bordon V, Al-Muhsen S, Al-Mousa H, Alsum Z, Al-Dhekri H, Al Ghonaium A, Speckmann C, Fischer A, Mahlaoui N, Nichols KE, Grunebaum E, Al Zahrani D, Roifman CM, Boelens J, Davies EG, Cavazzana-Calvo M, Notarangelo L, Gaspar HB (2012) Outcome of haematopoietic stem cell transplantation for adenosine deaminase deficient severe combined immunodeficiency. Blood 120:3615–3624
Immune Deficiency Foundation (2002) https://web.hsd.es/redip/docs/res_his_REDIP.pdf. Primary immune deficiency diseases in America: the first national survey of patients and specialists. https://www.primaryimmune.org/publications/surveys/second_national_survey_of_patients_(2002).pdf. Accessed on 5 May 2020
IPOPI (2020) International patient organization for primary immunodeficiencies. https://www.ipopi.org. Accessed on 5 May 2020
Kohn DB (2008) Gene therapy for childhood immunological diseases. Bone Marrow Transplant 41:199–205
Lambert G, Fattal E, Couvreur P (2001) Nanoparticulate systems for the delivery of antisense oligonucleotides. Adv Drug Deliv Rev 47:99–112
Lewandowicz-Uszyńska A, Jankowski A (2011) Intravenous immunoglobulin preparations in the treatment of primary immunodeficiency. Pol Merk Lek 180:409–412
Lewandowicz-Uszyńska A, Świerkot J, Jargulińska E, Jankowski A (2007) Common variable immunodeficiency. Cent Eur J Immunol 32(1):21–26
Lewandowicz-Uszyńska A, Szaflarska A, Pietrucha B, Wójcik J, Pochylczuk R, Kuśmirek B (2013) Standards of treatment with subcutaneous immunoglobulins in primary immunodeficiencies – guidelines for doctors and nurses drawn up by three immunology centers in Poland. In: Etzioni A, Gambineri E (eds) Proceeding of the 15th meeting of the European Society Immunodeficiencies – ESID. Florence (Italy), October 3–6, 2012. Medimond S.r.l, Bologna, pp 123–125. ISBN 978-88-7587-666-1
Locke BA, Dasu T, Verbsky JW (2014) Laboratory diagnosis of primary immunodeficiencies. Clin Rev Allergy Immunol 46(2):154–168
Ludvigsson JF, Neovius M, Ye W, Hammarström L (2015) IgA deficiency and risk of cancer: a population-based matched cohort study. J Clin Immunol 35(2):182–188
Malacarne F, Benicchi T, Notarangelo LD, Mori L, Parolini S, Caimi L, Hershfield M, Notarangelo LD, Imberti L (2005) Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients. Eur J Immunol 35:3376–3386
Markert ML, Devlin BH, McCarthy EA (2010) Thymus transplantation. Clin Immunol 135:236–246
Martínez García MA, de Rojas MD, Manzur NMD, Muñoz Pamplona MP, Compte Torrero L, Macián V, Perpiñá Tordera M (2001) Respiratory disorders in common variable immunodeficiency. Respir Med 95(3):191–195
McCusker C, Warrington R (2011) Primary immunodeficiency. Allergy Asthma Clin Immunol 7:S1–S11
Merten OW, Charrier S, Laroudie N, Fauchille S, Dugué C, Jenny C, Audit M, Zanta-Boussif MA, Chautard H, Radrizzani M, Vallanti G, Naldini L, Noguiez-Hellin P, Galy A (2011) Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application. Hum Gene Ther 22:343–356
Moens LN, Falk-Sorqvist E, Asplund AC, Bernatowska E, Smith CI, Nilsson M (2014) Diagnostics of primary immunodeficiency diseases: a sequencing capture approach. PLoS One 9(12):e114901
Moore ML, Quinn JM (2008) Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century. Ann Allergy Asthma Immunol 101(2):114–121
Mortaz E, Tabarsi P, Mansouri D, Khosravi A, Garssen J, Velayati A, Adcock IM (2016) Cancers related to Immunodeficiencies: update and perspectives. Front Immunol 7:365
Mountain A (2000) Gene therapy: the first decade. Trends Biotechnol 18:119–127
Mukherjee S, Thrasher AJ (2013) Gene therapy for PIDs: progress, pitfalls and prospects. Gene 525:174–181
Nijman IJ, van Montfrans JM, Hoogstraat M, Boes ML, van de Corput L, Renner ED, van Zon P, van Lieshout S, Elferink MG, van der Burg M, Vermont CL, van der Zwaag B, Janson E, Cuppen E, Ploos van Amstel JK, van Gijn ME (2014) Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. J Allergy Clin Immunol 133:529–534
Noordzij JG, de Bruin-Versteeg S, Hartwig NG, Weemaes CM, Gerritsen EJ, Bernatowska E, van Lierde S, de Groot R, van Dongen JJ (2002) XLA patients with BTK splice-site mutations produce low levels of wild-type BTK transcripts. J Clin Immunol 22:306–318
Notarangelo L, Casanova JL, Fischer A, Puck J, Rosen F, Seger R, Geha R (2004) Primary immunodeficiency diseases: an update. J Allergy Clin Immunol 114:677–687
Ochs HD, Smith CIE, Puck JM (2014) Primary immunodeficiency diseases. A molecular and genetic approach. Oxford University Press, New York
Onodera M, Ariga T, Kawamura N, Kobayashi I, Ohtsu M, Yamada M, Tame A, Furuta H, Okano M, Matsumoto S, Kotani H, McGarrity GJ, Blaese RM, Sakiyama Y (1998) Successful peripheral T-lymphocyte-direct gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency. Blood 91:30–36
OʼSullivan MD, Cant AJ (2012) The 10 warning signs: a time for a change? Curr Opin Allergy Clin Immunol 12(6):588–594
Patuzzo G, Barbieri A, Tinazzi E, Veneri D, Argentino G, Moretta F, Puccettio P, Lunardi C (2016) Autoimmunity and infection in common variable immunodeficiency (CVID). Autoimmun Rev 15(9):877–882
Pessach IM, Notarangelo LD (2011) Gene therapy for primary immunodeficiencies: looking ahead, toward gene correction. J Allergy Clin Immunol 127(6):1344–1350
Piątosa B, Pac M, Siewiera K, Pietrucha B, Klaudel-Dreszler M, Heropolitańska-Pliszka E, Wolska-Kuśnierz B, Dmeńska H, Gregorek H, Sokolnicka I, Rękawek A, Tkaczyk K, Bernatowska E (2013) Common variable immune deficiency in children – clinical characteristics varies depending on defect in peripheral B cell maturation. J Clin Immunol 33:731–741
Pietrucha B, Heropolitañska-Pliszka E, Gatti RA, Bernatowska E (2007) Ataxia-telangiectasia: guidelines for diagnosis and comprehensive care. Cent Eur J Immunol 32(4):234–238
Pietrucha B, Gregorek H, Heropolitańska-Pliszka E, Bernatowska E (2018) Primary immunodeficiency with double strain break DNA (DSBs) and radiosensitvity: clinical, diagnostic and therapeutic implications. Postepy Hig Med Dosw 72:449–460. (Article in Polish)
Podralska MJ, Stembalska A, Ślęzak R, Lewandowicz-Uszyńska A, Pietrucha B, Kołtan S, Wigowska-Sowińska J, Pilch J, Mosor M, Ziółkowska-Suchanek I, Dzikiewicz-Krawczyk A, Słomski R (2014) Ten new ATM alterations in polish patients with ataxia-telangiectasia. Mol Genet Genomic Med 2:504–511
Raje N, Soden S, Swanson D, Ciaccio CE, Kingsmore SF, Dinwiddie DL (2014) Utility of next generation sequencing in clinical primary immunodeficiencies. Curr Allergy Asthma Rep 14:468
Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C (2012) Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119:1650–1657
Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, Aghamohammadi A (2009) Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 155:21–27
Rich R, Fleisher A, Shearer T, Schroeder H, Frew A, Weyand C (2001) Clinical immunology – principles and practice. Mosby, London
Rochman Y, Spolski R, Leonard WJ (2009) New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol 9:480–490
Routes J, Abinun M, Al-Herz W, Condino-Neto A, De La Morena MT, Etzioni A, Gambineri E, Haddad E, Kobrynski L, Le Deist F, Nonoyama S, Oliveira JB, Perez E, Picard C, Rezaei N, Sleasman J, Sullivan KE, Torgerson T (2014) ICON: the early diagnosis of congenital immunodeficiencies. J Clin Immunol 34(4):398–424
Roy-Ghanta S, Orange JS (2010) Use of cytokine therapy in primary immunodeficiency. Clin Rev Allergy Immunol 38:39–53
Sauer AV, Brigida I, Carriglio N, Aiut A (2012) Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency. Front Immunol 3:265
Shehata N, Palda V, Bowen T, Haddad E, Issekutz TB, Mazer B, Schellenberg R, Warrington R, Easton D, Anderson D, Hume H (2010) The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline. Transfus Med Rev 24:S28–S50
Spickett GP, Farrant J, North ME (1997) Common variable immunodeficiency: how many diseases? Immunol Today 18(7):325–328
Stoddard JL, Niemela JE, Fleisher TA, Rosenzweig SD (2014) Targeted NGS: a cost-effective approach to molecular diagnosis of PIDs. Front Immunol 5:531
Świerkot J, Lewandowicz-Uszyńska A (2007) Autoimmune disorders in the course of primary immunodeficiency. Cent Eur J Immunol 32(1):27–33
Tangye SG, Al-Herz W, Aziz BA, Chatila T, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM, Klein C, Morio T, Ochs DO, Oksenhendler E, Picard C, Puck J, Torgerson TR, Casanova JL, Sullivan KE (2020) Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 40:24–64
Touzot F, Hacein-Bey-Abina S, Fischer A, Cavazzana M (2014) Gene therapy for inherited immunodeficiency. Expert Opin Biol Ther 14:789–798
Van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJ (2007) Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med 204:645–655
Van Zelm MC, van der Burg M, Langerak AW, van Dongen JJM (2011) PID comes full circle: applications of V(D)J recombination excision circles in research, diagnostics and newborn screening of primary immunodeficiency disorders. Front Immunol 2:12
Wolska-Kuśnierz B, Gregorek H, Chrzanowska K, Piątosa B, Pietrucha B, Heropolitańska-Pliszka E, Pac M, Klaudel-Dreszler M, Kostyuchenko L, Pasic S, Marodi L, Belohradsky BH, Čižnár P, Shcherbina A, Kilic SS, Baumann U, Seidel MG, Gennery AR, Syczewska M, Mikołuć B, Kałwak K, Styczyński J, Pieczonka A, Drabko K, Wakulińska A, Gathmann B, Albert MH, Skarżyńska U, Bernatowska E, Inborn Errors Working Party of the Society for European Blood and Marrow Transplantation and the European Society for Immune Deficiencies (2015) Nijmegen breakage syndrome: clinical and immunological features, long-term outcome and treatment options a retrospective analysis. J Clin Immunol 35:538–549
Wysoczańska B (2008) T-cell receptor rearrangement excision circles (TRECs) as a marker of thymic function. Postepy Hig Med Dosw (Online) 62:708–724. (Article in Polish)
Conflicts of Interest
The authors declare that they have no conflict of interest in relation to this article.
Ethical Approval
This review article does not contain any studies with human participants or animals performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lewandowicz-Uszyńska, A., Pasternak, G., Świerkot, J., Bogunia-Kubik, K. (2020). Primary Immunodeficiencies: Diseases of Children and Adults – A Review. In: Pokorski, M. (eds) Medical and Biomedical Updates. Advances in Experimental Medicine and Biology(), vol 1289. Springer, Cham. https://doi.org/10.1007/5584_2020_556
Download citation
DOI: https://doi.org/10.1007/5584_2020_556
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-67215-7
Online ISBN: 978-3-030-67216-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)